Josh Charles' Best Medicine bows early, Stephen Fry debuts Feb 9

# Josh Charles' Best Medicine Ends Season 2B With 14‑Episode Finale Before Stephen Fry Debuts The Interrogator Feb. 9 Fox Television’s latest mid‑season slate has just been revealed, and the lineup promises a mix of familiar faces, fresh drama, and a splash of nostalgic revivals.

With Thanksgiving looming, the network is positioning its key properties to capture viewers in the holiday rush and beyond. At the heart of the schedule is *Best Medicine*, the long‑running medical drama starring Josh Charles, Abigail Spencer and Annie Potts.

After a shortened 14‑episode season, the show bows on January 6 at 8 p.m. before the premiere of *Doc*’s Season 3B. A month later, Stephen Fry will take center stage as the lead in the new legal thriller *The Interrogator*, slated to debut February 9.

The announcements also bring back fan‑favorites and introduce new formats. *The Masked Singer* enters its fifteenth season on the same day at 8 p.m., followed immediately by the reimagined *Baywatch* at 9 p.m.

The survival competition *Extracted* opens with a two‑hour premiere on January 7 before moving into its regular slot. Meanwhile, crime‑drama enthusiasts will get a double dose of new series on February 1, with *Murder in a Small Town* Season 3 and *Memory of a Killer* Season 2.

The culinary world is treated to *Next Level Chef*’s sixth season on February 18.

Notably, the network has left out any comedy or Sunday programming, signaling a focused push on drama and reality competition to dominate prime‑time ratings. ## Background & Context The mid‑season schedule is a crucial strategic tool for networks, especially in the lead‑up to Thanksgiving, a period when audiences are fragmented across travel, family gatherings, and holiday specials.

By front‑loading its strongest dramas and reality shows, Fox aims to retain viewers who might otherwise drift to streaming platforms during the long holiday break.

The choice to shorten *Best Medicine* to 14 episodes, down from the typical 20‑plus count, reflects a shift toward tighter, more emotionally resonant story arcs that can keep audiences engaged without the filler that sometimes plagues longer seasons.

Josh Charles has been a reliable anchor for the series since its 2016 premiere. His portrayal of Dr.

Matt Redding brings a blend of gravitas and vulnerability that has become a staple of the show’s identity.

The decision to conclude Season 2B in early January also aligns with the network’s intent to clear the way for *The Interrogator*—a fresh concept that blends courtroom drama with psychological profiling, led by the British actor‑writer Stephen Fry.

This cross‑Atlantic collaboration is anticipated to broaden Fox’s demographic reach, attracting both American viewers who appreciate Fry’s intellectual wit and younger audiences drawn to the procedural intensity.

The reintroduction of *Baywatch* alongside *The Masked Singer* is a calculated move to leverage nostalgia while injecting contemporary relevance. *The Masked Singer* has proven to be a ratings powerhouse, consistently outperforming competitors in the 18‑49 demographic.

Its presence at 8 p.m. provides a strong lead‑in for the 9 p.m. slot, which now features the new *Baywatch* series that aims to modernize the iconic lifeguard saga with diverse casting and contemporary storylines.

By sandwiching the reboot between two high‑performing shows, Fox hopes to create a prime‑time block that is difficult for rivals to match. ## What People Are Saying Within the industry, there is a mixture of excitement and cautious optimism about the new slate.

Industry analysts have praised the network for its boldness in pairing a storied medical drama with a brand‑new legal thriller. “Fox is taking calculated risks,” one executive said, noting that Stephen Fry’s involvement brings a level of gravitas that could elevate the network’s profile.

Meanwhile, fans of *Best Medicine* are already discussing the implications of a shorter season, with many hoping that the tighter narrative will allow deeper character exploration rather than sprawling procedural arcs.

The decision to keep *The Masked Singer* and *Baywatch* in the same evening has sparked conversations on fan forums.

Some viewers argue that the juxtaposition could dilute the audience for the latter, while others believe that the high‑energy performance show will attract a younger crowd that might stay for the nostalgic drama.

Social media threads are buzzing with speculation about potential crossover moments or surprise guest appearances, adding to the anticipation for the January 6 premiere night. Industry insiders also point out the absence of a comedy lineup for the upcoming season.

“It’s a bold move,” remarked a television strategist, . By concentrating on drama and reality competition, Fox seems intent on positioning itself as the go‑to destination for high‑stakes entertainment during the most critical viewership period of the year.

The strategy could pay off if the new shows resonate with audiences, but the gamble carries risk if viewers feel the lack of. ## What Happens Next Looking ahead, the real test for Fox will be how the new shows perform in the crucial January ratings window.

The 8 p.m. and 9 p.m. slots are highly coveted, and any dip in viewership could prompt swift schedule adjustments. The network’s programming team will be watching the performance of *The Interrogator* closely, as its success could signal a new direction for Fox’s drama offerings.

Meanwhile, *Best Medicine*’s final episodes will need to deliver emotional closure that satisfies longtime fans while setting the stage for a possible renewal or spin‑off in future seasons. On the production side, the early release of the mid‑season schedule allows studios and talent to align their creative calendars.

Writers’ rooms for the new shows can now plan arcs with tighter deadlines, while actors can prepare for the demands of a condensed shooting schedule.

The industry also watches the scheduling of *Extracted* and *Murder in a Small Town* with interest, as these series provide valuable insight into the network’s broader strategy of balancing reality competition with scripted crime drama.

Beyond the immediate horizon, Fox’s handling of this slate could influence other networks’ planning. Should the new shows capture significant ratings, competitors may feel pressure to reallocate resources toward similar high‑intensity programming.

Conversely, if viewership falters, we may see a reversion to the more traditional mix of sitcoms, reality series, and family‑friendly dramas that have historically filled the mid‑season slots.

In the end, the 2027 mid‑season lineup represents both a nod to what has worked in the past and an experiment in redefining Fox’s brand for a changing audience landscape.

As viewers settle in for the holiday season and beyond, all eyes will be on the January 6 premieres to gauge whether Fox’s gamble pays off or if the network will need to recalibrate its approach in the months that follow.